Business Wire - Techseriesinsight

November 15, 2024
Business Wire
Biotechnology

Anaergia Awarded Contract to Operate and Maintain Rialto Bioenergy Solutions Facility in California

Anaergia Inc. (“Anaergia”, the “Company”, “we”, “us”, or “our”) (TSX: ANRG) announced today that its subsidiary, Anaergia Services LLC (“Anaergia Services”), has entered into a long-term Operations and Maintenance...

November 15, 2024
Business Wire
Business Broadcast

FPT and Ericsson Join Forces to Propel 5G-Driven AI, Data, and Digital Transformation

Global technology corporation FPT and Global ICT leader Ericsson have entered a partnership to accelerate 5G adoption and drive advancements in artificial intelligence (AI) and digital transformation. This collaboration...

November 14, 2024
Business Wire
Artificial Intelligence

Accenture Launches Center for Advanced AI in Kyoto to Help Clients Reinvent with Generative AI

Accenture (NYSE: ACN) today announced the opening of the Accenture Center for Advanced AI Kyoto, a state-of-the-art facility dedicated to empowering clients with cutting-edge AI technologies, particularly generative AI,...

November 14, 2024
Business Wire
Artificial Intelligence

AppSOC Recognized as an AI TRiSM Vendor in the 2024 Gartner® Use TRiSM to Manage AI Governance, Trust, Risk and Security report

AppSOC, a leader in AI security and governance solutions, is proud to announce its mention as a Sample AI TRiSM Vendor in the Gartner latest report Use TRiSM to...

November 14, 2024
Business Wire
Healthcare

Sg2 Data Highlights Urgency for Increased Cardiovascular Intervention Resources in US Hospitals

Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and related challenge of timely patient access to lifesaving interventions...

November 13, 2024
Business Wire
Biotechnology

GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today...

November 13, 2024
Business Wire
Biotechnology

VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain

VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced therapies...

November 13, 2024
Business Wire
Artificial Intelligence

Global Relay Announces Next Gen AI-Enabled Communications Surveillance

Global Relay, a leading provider of integrated digital communications and recordkeeping, announces its AI-enabled surveillance solution to support the increased need for communications surveillance to meet evolving regulatory requirements....

November 13, 2024
Business Wire
Biotechnology

CARMAT’s Aeson® Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the...

November 13, 2024
Business Wire
Artificial Intelligence

FPT Launches FPT AI Factory to Accelerate AI Development in Japan, Offering Local Companies Pre-Orders for its NVIDIA H200 Tensor Core GPUs Cloud Service

FPT, a global leading IT firm and Preferred NVIDIA Cloud Partner (NCP), officially announced the launch of the FPT AI Factory in Japan using the full-stack NVIDIA accelerated computing...